TY  - JOUR 
AU  - Santos, J.R.
AU  - Casadellà, M.
AU  - Noguera-Julian, M.
AU  - Micán-Rivera, R.
AU  - Domingo, P.
AU  - Antela López, Antonio
AU  - Portilla, J.
AU  - Sanz, J.
AU  - Montero-Alonso, M.
AU  - Navarro, J.
AU  - Masiá, M.
AU  - Valcarce Pardeiro, Nieves
AU  - Ocampo Hermida, Antonio
AU  - Pérez-Martínez, L.
AU  - García-Vallecillos, C.
AU  - Vivancos, M.J.
AU  - Imaz, A.
AU  - Iribarren, J.A.
AU  - Hernández-Quero, J.
AU  - Villar-García, J.
AU  - Barrufet, P.
AU  - Paredes, R.
PY  - 2023
SN  - 2235-2988
UR  - http://hdl.handle.net/20.500.11940/21402
AB  - Introduction: Second-generation integrase strand transfer inhibitors (INSTIs) are preferred treatment options worldwide, and dolutegravir (DTG) is the treatment of choice in resource-limited settings. Nevertheless, in some resource-limited settings,...
LA  - eng
KW  - Adult
KW  - Humans
KW  - Spain
KW  - Prospective Studies
KW  - Cobicistat
KW  - Integrases
KW  - HIV Infections
TI  - Effectiveness and safety of integrase strand transfer inhibitors in Spain: a prospective real-world study
DO  - 10.3389/fcimb.2023.1187999
T2  - Frontiers in Cellular and Infection Microbiology
KW  - AS Santiago
KW  - CHUS
KW  - AS Ferrol
KW  - CHUF
KW  - AS Vigo
KW  - CHUVI
VL  - 13
ER  -